Clinical trial

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.

NCT06678555

Study summary

ClinicalTrials.gov

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Lorlatinib Normalized identity: lorlatinib View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2025-07-04

PhaseN/A

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

LorlatinibDRUG · verified · RxNorm: lorlatinib

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06678555 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.